TrialInternational journal of clinical practice2009

Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study.

S Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.